This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
Healthcare Outperformance May Signal Short-Term Market Bottom
by Bryan Hayes
This sector outperformance may be a sign the market is nearing a point of selling exhaustion.
biotechnology biotechs cancer coronavirus dividend-investing dividends earnings etfs investing large-cap pharmaceuticals
The Commodity Surge: Is It Too Late to Buy These Leading Oil and Gas Stocks?
by Bryan Hayes
With crude prices continuing to move higher, investors would be wise to consider an allocation to these stocks.
coronavirus earnings energy investing large-cap oil-energy
BioPharma Giants Print Fresh All-Time Highs
by Bryan Hayes
The trend is our friend in this market, and these two biopharmaceutical stocks are trending exceptionally well.
biotechnology cancer cell-therapy coronavirus earnings genetics hospitals immuno-therapy investing large-cap medical medical-devices pharmaceuticals
Is It Time to Give Chinese Stocks the Green Light?
by Bryan Hayes
The notion of China weighing down emerging markets is far from a new reality.
coronavirus e-commerce earnings emerging-markets etfs internet internet-content investing large-cap
Bull Of The Day: DocGo (DCGO)
by Brian Bolan
It may still be very early, but this company could change the way we think of non-emergency healthcare
autonomous-vehicles coronavirus medical-devices smart-health
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns
coronavirus medical
Medical IT Providers Marching to Their Own Beat
by Bryan Hayes
Medical IT Providers Marching to Their Own Beat
artificial-intelligence cloud-computing coronavirus dividend-investing dividends earnings hospitals investing large-cap medical smart-health software vaccines
The Disinformation Effect: Media Companies Soar on Growth Prospects
by Bryan Hayes
The Disinformation Effect: Media Companies Soar on Growth Prospects
advertising coronavirus earnings internet internet-content investing media social-media
Stay to Play: Hotel Giants Displaying Relative Strength
by Bryan Hayes
Stay to Play: Hotel Giants Displaying Relative Strength
consumer-discretionary coronavirus dividend-investing dividends earnings investing large-cap restaurants travel-leisure
The Stealth Bear Market: Nearing an End or More Pain Ahead?
by Bryan Hayes
The Stealth Bear Market: Nearing an End or More Pain Ahead?
coronavirus dividend-investing dividends earnings energy investing large-cap oil-energy